Author

Matthew J. Reichlen

University of Colorado Anschutz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Approach:statistical model· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:metagenomics· 1 Assay:proteomics· 1

Frequent Co-Authors

Gregory T. RobertsoniD· 2 shared Martin I. VoskuiliD· 2 shared Nicholas D. WalteriD· 2 shared Samuel T. TaboriD· 2 shared Allan D. FrieseniD· 1 shared Ashley M Gerwing· 1 shared Christian Dide-AgossouiD· 1 shared Emmanuel MusisiiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Gregory T. RobertsonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Same class, different activity: Delamanid and pretomanid have comparable bactericidal activity but pretomanid potently inhibits Mycobacterium tuberculosis ribosomal rRNA synthesis

Matthew J. Reichlen, Emmanuel Musisi, Samuel T. Tabor, Holly Nielson, Ashley M Gerwing, Firat Kaya, Matthew D. Zimmerman, Martin I. Voskuil, Gregory T. Robertson, Nicholas D. Walter

This study compares delamanid and pretomanid, finding similar bactericidal activity but pretomanid more effectively inhibits M. tuberculosis ribosomal rRNA synthesis.

bioRxiv · Dec 30, 2025 · PreprintMicrobiology

Mind the gap: Understanding discordance between culture- and a non-culture-based measure of bacterial burden in murine tuberculosis treatment models

Samuel T. Tabor, Allan D. Friesen, Matthew J. Reichlen, Christian Dide-Agossou, Max McGrath, Ryan Peterson, Vitaly V. Ganusov, Gregory T. Robertson, Martin I. Voskuil, Nicholas D. Walter

This study evaluates the CFU-16S rRNA gap in tuberculosis treatment models, finding that the discrepancy is partially due to residual 16S rRNA from dead bacteria and potential transient viable but non-culturable populations.

bioRxiv · Dec 18, 2025 · PreprintMicrobiology